• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Other Campus Research
    • Open Access
    • View Item
    •   ScholarShip Home
    • Other Campus Research
    • Open Access
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response

    Thumbnail
    View/ Open
    1479-5876-10-162.pdf (408.4Kb)

    Show full item record
    Author
    Salom, Emery; Penalver, Manuel; Homesley, Howard; Burrell, Matthew; Garrett, Audrey; Presant, Cary A; Rutledge, James; Chernick, Michael; Hallquist, Allan; Perree, Mathieu
    Abstract
    This study was performed to determine if a chemotherapy-induced apoptosis assay (MiCK) could predict the best therapy for patients with ovarian cancer. A prospective, multi-institutional and blinded trial of the assay was conducted in 104 evaluable ovarian cancer patients treated with chemotherapy. The MiCK assay was performed prior to therapy, but treating physicians were not told of the results and selected treatment only on clinical criteria. Outcomes (response, time to relapse, and survival) were compared to the drug-induced apoptosis observed in the assay. The MiCK assay can predict the chemotherapy associated with better outcomes in ovarian cancer patients. This study quantifies outcome benefits on which a prospective randomized trial can be developed.
    URI
    http://hdl.handle.net/10342/7855
    Date
    2012-08-08
    Citation:
    APA:
    Salom, Emery, & Penalver, Manuel, & Homesley, Howard, & Burrell, Matthew, & Garrett, Audrey, & Presant, Cary A, & Rutledge, James, & Chernick, Michael, & Hallquist, Allan, & Perree, Mathieu. (August 2012). Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response. , (), - . Retrieved from http://hdl.handle.net/10342/7855

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Salom, Emery, and Penalver, Manuel, and Homesley, Howard, and Burrell, Matthew, and Garrett, Audrey, and Presant, Cary A, and Rutledge, James, and Chernick, Michael, and Hallquist, Allan, and Perree, Mathieu. "Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response". . . (), August 2012. September 25, 2023. http://hdl.handle.net/10342/7855.
    Chicago:
    Salom, Emery and Penalver, Manuel and Homesley, Howard and Burrell, Matthew and Garrett, Audrey and Presant, Cary A and Rutledge, James and Chernick, Michael and Hallquist, Allan and Perree, Mathieu, "Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response," , no. (August 2012), http://hdl.handle.net/10342/7855 (accessed September 25, 2023).
    AMA:
    Salom, Emery, Penalver, Manuel, Homesley, Howard, Burrell, Matthew, Garrett, Audrey, Presant, Cary A, Rutledge, James, Chernick, Michael, Hallquist, Allan, Perree, Mathieu. Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response. . August 2012; (): . http://hdl.handle.net/10342/7855. Accessed September 25, 2023.
    Collections
    • Open Access

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback